Author:
Skvortsova V. I.,Shetova I. M.,Kakorina E. P.,Kamkin E. G.,Boiko E. L.,Alekyan B. G.,Ivanova G. E.,Shamalov N. A.,Dashyan V. G.,Krylov V. V.
Publisher
Media Sphere Publishing Group
Subject
Psychiatry and Mental health,Clinical Neurology
Reference24 articles.
1. Krishnamurthi RV, Feigin VL, Forouzanfar MHb, Mensah GA, Connor M on behalf of the Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet Global Health. 2013;1(5):259-281.
2. Skvortsova VI, Stakhovskaya LV, Ayrian NYu. Stroke epidemiology in Russian. Consilium Medicum. 2005;7(1):4-9. (In Russ.)
3. Stroke. A guide for doctors. Ed. Stakhovskoy LV, Kotova SV. M.: MIA; 2014. (In Russ.) National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen Activator For Acute Ishemic Stroke. The New England Journal of Medicine. 1995;333(24): 47-52.
4. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, for the ECASS Study Group. Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):53-59.
5. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245-1251.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献